Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
65.10
+0.05 (0.08%)
Oct 7, 2024, 4:00 PM EDT - Market closed

Utah Medical Products Revenue

Utah Medical Products had revenue of $10.40M in the quarter ending June 30, 2024, a decrease of -19.17%. This brings the company's revenue in the last twelve months to $46.58M, down -10.28% year-over-year. In the year 2023, Utah Medical Products had annual revenue of $50.22M, down -3.93%.

Revenue (ttm)
$46.58M
Revenue Growth
-10.28%
P/S Ratio
5.04
Revenue / Employee
$245,147
Employees
190
Market Cap
226.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.22M-2.06M-3.93%
Dec 31, 202252.28M3.23M6.58%
Dec 31, 202149.05M6.88M16.30%
Dec 31, 202042.18M-4.73M-10.08%
Dec 31, 201946.90M4.91M11.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fulcrum Therapeutics 81.63M
SOPHiA GENETICS 64.94M
Codexis 60.89M
MacroGenics 41.02M
Zentalis Pharmaceuticals 40.56M
Sera Prognostics 107.00K
Revenue Rankings